Wandercraft

Scores by criterion

Each criterion is defined on our methodology page.

Who uses Wandercraft and what it's for

Rehabilitation centers buy Atalante X and EksoNR for gait training. Between them the two platforms hold FDA clearances and CE marks covering stroke, spinal cord injury, multiple sclerosis, and acquired brain injury.³

Eve and Ekso's Indego Personal serve eligible people with spinal cord injuries at home. Wandercraft says Medicare covers qualifying exoskeletons under its brace benefit category for patients who meet eligibility and medical necessity criteria.^4,5

Atalante X, Eve, and Calvin

Wandercraft was founded in Paris in 2012 by Nicolas Simon, Matthieu Masselin, and Jean-Louis Constanza. Atalante was cleared by the FDA for stroke rehabilitation, which opened US clinics, and its technology is used at more than 150 clinical and research sites.²

The same self-balancing technology drives Calvin, a humanoid robot for heavy, repetitive industrial work. Renault Group took a stake and became an industrial partner alongside a Series D round.^2,6

The Ekso Bionics deal

Wandercraft bought Ekso Bionics from a subsidiary of ChronoScale Holdings, and the deal was signed and closed at the same time. Financial terms were not disclosed.³

Chief executive Matthieu Masselin told IZON the combined company can produce up to 2,000 units a year at its Paris facility and now has manufacturing in France and the US.⁴

Competitive landscape

Limits

Wandercraft publishes no device prices, so clinics and individuals need a quote and, for personal use, an insurance decision.⁵

Integrating Ekso while launching Eve and building a humanoid stretches a company that was much smaller than its new footprint.^4,2

Revenue is not disclosed. We estimate the combined company at $15 million to $25 million a year, based on Ekso Bionics' 2025 revenue of $12.8 million and Wandercraft's own sales before the deal. This is an estimate, not a reported figure.^7,6

What customers say

Where it helps

Atalante X and EksoNR have years of clinical use behind them, and Wandercraft says its technology has taken more than 25 million real-world steps.^1,3

Paris 2024 gave the company a public showcase: its exoskeletons carried the Olympic and Paralympic torches, including for Thibault Simon, whose brother co-founded Wandercraft.²

Where it falls short

We found no independent buyer reviews comparing Atalante X with other gait trainers on cost. Clinics should ask for utilization data from similar centers before buying.²

Leadership

• Matthieu Masselin

  Founder and CEO

  Masselin co-founded Wandercraft in Paris in 2012 and led its October 2026 acquisition of Ekso Bionics.^2,4

  Read full profile

• Nicolas Simon

  Founder, AI and controls

  Simon watched a robot learn to walk in a university robotics club and thought of his brother, who was losing the ability to walk.²

• Jean-Louis Constanza

  Founder, humanoids business development

  Constanza co-founded Wandercraft and now works on business development for its Calvin humanoid robots.²

Sources